Cannabis Tax Revenue by State 2026: $26 Billion and Counting
This includes excise taxes, sales taxes applied to cannabis, and related fees, though figures vary by state reporting (some exclude medical-only revenue, local taxes, or licensing fees).
In 2024 alone, adult-use states collected more than $4.4 billion—the highest single-year total—with cumulative adult-use revenue exceeding $24.7 billion through much of 2025 data. Revenues support education, public safety, health programs, social equity, infrastructure, and general funds, though exact allocations differ widely.
Top Revenue-Generating States (Recent Annual Figures)
Here are highlights from major markets (approximate; fiscal/calendar years vary):
- California: ~$1.05 billion in 2025 (down slightly from prior years due to market saturation and price compression). Cumulative since 2018: over $7.8–8+ billion. 15% excise tax + sales tax.
- Colorado: ~$236 million in 2025 (sales >$1.1 billion). Cumulative adult-use since 2014: ~$2.6–2.7 billion. Dual 15% wholesale/retail taxes.
- Washington: Hundreds of millions annually (e.g., ~$500+ million in recent peak years). Cumulative: ~$4.7 billion+. High 37% retail excise.
- Michigan: Strong performer; part of top-tier states generating hundreds of millions yearly.
- Illinois, Arizona, Ohio, New York, etc.: Many exceed $100–300+ million annually as markets mature.
Smaller or newer markets (e.g., Alaska, Connecticut) generate tens of millions. Medical-only states add more (often via sales taxes), but recreational drives the bulk.
Tax Structures (as of 2026)
States use varied approaches—ad valorem (percentage of price), weight-based, THC potency, or hybrids—which affect revenue stability and market competitiveness:
- Percentage-based (common): Arizona (16%), California (15%), Colorado (15% wholesale + 15% retail), Washington (37%—highest), etc.
- Weight/THC: Alaska ($50/oz flower), Connecticut/New York/Illinois (potency-based elements).
- Recent changes: Some states adjusted rates (e.g., Michigan added wholesale tax, Minnesota increased to 15%, New Mexico phasing up) amid budget needs or to support roads/education.
Note: Revenues have faced pressure from illicit market competition, price declines, and oversupply in mature states, leading to flat or modest dips in some 2024–2025 figures despite volume growth. Newer states (e.g., New York, Ohio) are ramping up and boosting national totals.
Broader Trends
- Cumulative Impact: Over $25–26 billion total across programs, a small but growing share of state budgets (often directed to specific funds rather than general revenue).
- Challenges: High taxes in some states sustain black markets; federal prohibition limits interstate commerce and banking. Rescheduling (medical to Schedule III) helps taxes/280E but doesn't fully resolve issues.
- No Rollbacks: Revenues remain positive with no states reversing legalization; many allocate to equity, schools, and harm reduction.
Data evolves quickly—sources like the Marijuana Policy Project (MPP), Tax Foundation, state departments of revenue, and Motley Fool trackers provide the most current breakdowns. For a specific state, check official fiscal reports, as Q1/Q2 2026 partial data shows continued collections in the hundreds of millions nationally.
Field Notes, Not Brochure Copy
The Stoner Review writes from the smoke spot: what burned clean, what tasted like marketing, and what we would spend on again. If a claim cannot survive a real session, it does not survive our page.
How to Read This Like a Head
Take what helps. Ignore the flex. Cross-check jars with your own nose. The best cannabis writing should make you a sharper shopper, not a louder commenter.
Stay in the Room
Algorithms throttle. Brands rebrand. The circle outside still decides who gets the next light based on whether you feel real. Keep showing up for the culture that still remembers where it came from.
One More Pass From the Notebook
We keep revisiting jars, floors, and fits because cannabis culture is not a press release — it is a practice. Come back tomorrow with a clearer nose, a sharper question, and less patience for potency theater. The Stoner Review will still be here, writing like the Wi-Fi might die and the circle outside is the only network that matters.
Support independent cannabis media when the algorithm gets weird. Share the pieces that help somebody shop smarter. And when a brand tries to sand the joke off the plant, remember who was in the room first.
One More Pass From the Notebook
We keep revisiting jars, floors, and fits because cannabis culture is not a press release — it is a practice. Come back tomorrow with a clearer nose, a sharper question, and less patience for potency theater. The Stoner Review will still be here, writing like the Wi-Fi might die and the circle outside is the only network that matters.
Support independent cannabis media when the algorithm gets weird. Share the pieces that help somebody shop smarter. And when a brand tries to sand the joke off the plant, remember who was in the room first.
Keep Reading on The Stoner Review
More field notes from the same smoke-stained notebook:
Find more gritty, honest stories, strain reviews, travel guides, and multi-minded stoner perspectives at theStonerReview.com/blog.
